Biocardia Inc (BCDA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $12.58M
Last updated: Nov 17, 2026 at 4:10 PM ET
Biocardia Inc (BCDA) Statistics
Biocardia (BCDA) has a market cap of $12.58M and an enterprise value of $10.36M. It holds $2.22M more cash than debt, 17.68% of its market cap.
Total Valuation
Enterprise value is 17.68% below the market cap, as cash exceeds debt.
| Market Cap | $12.58M |
|---|---|
| Enterprise Value | $10.36M |
| Latest price (Nov 17, 2026) | $0.79 |
Key Dates
The next earnings report is expected on Mar 22, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 22, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 35.92% over 52 weeks and trades 20.20% below its 50-day average.
| Beta (1Y) | 0.57 |
|---|---|
| 52-Week Change | -35.92% |
| 1-Month Change | -12.18% |
| 3-Month Change | -20.46% |
| 6-Month Change | -17.11% |
| 5-Year Change | -97.95% |
| 10-Year Change | -96.04% |
| Total Return (1Y) | -35.92% |
| Total Return (3Y CAGR) | -58.22% |
| Total Return (5Y CAGR) | -52.55% |
| Max Drawdown (1Y) | -47.54% |
| Max Drawdown (3Y) | -92.86% |
| Sharpe Ratio (1Y) | -0.73 |
| Correlation with SPY (1Y) | 0.11 |
| 50-Day Average | $0.99 |
| 200-Day Average | $1.05 |
| 52-Week Range | $0.66 to $1.50 |
| RSI (14 Days) | 35.6 |
| Average Volume (20 Days) | 90.04K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.11x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.11x |
|---|---|
| Quick Ratio | 1.11x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -918.92% and return on assets is -249.85% over the last 12 months.
| Return on Equity (ROE) | -918.92% |
|---|---|
| Return on Assets (ROA) | -249.85% |
Scores
BCDA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Gross Profit | -$185.00K |
| Operating Income | -$7.74M |
| Pretax Income | -$7.07M |
| Net Income | -$7.67M |
| Reported EPS (TTM) | -$0.52 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 27.20% of the $3.07M in total assets.
| Cash and Equivalents | $2.22M |
|---|---|
| Total Debt | $0 |
| Net Cash | $2.22M |
| Net Cash Per Share | $0.15 |
| Working Capital | $240.00K |
| Shareholder Equity | $835.00K |
| Book Value Per Share | $0.06 |
| Total Assets | $3.07M |
| Total Liabilities | $2.24M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$7.61M |
|---|---|
| FCF Per Share | -$0.50 |
| Depreciation and Amortization | $553.00K |
| Share Repurchases | $433.00K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
BCDA does not pay a dividend.
| Buyback Yield | -40.87% |
|---|---|
| Shareholder Yield | -40.87% |
Stock Splits
The last split was a 1-for-15 reverse split on May 30, 2024.
| Last Split Date | May 30, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About BCDA
What is BCDA's market cap?
Biocardia has a market cap of $12.58M. Its enterprise value, which adds debt and subtracts cash, is $10.36M.
How many shares of BCDA are outstanding?
Biocardia has 15.14M shares outstanding.
Does BCDA pay a dividend?
No. Biocardia does not pay a dividend.
How much debt does BCDA have?
Biocardia has $0 of total debt and $2.22M of cash and equivalents, a net cash position of $2.22M.
BCDA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors